SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NSIX -- Neuromedical Systems, Inc.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Daniel Rimar who wrote (5)9/10/1997 9:51:00 PM
From: David and Elena Krikorian   of 137
 
Hello Dan,

Thanks for clearing the dust off this thread. As for NSIX, I have been following this stock for the past 6 months and I finally took a position in it (25 NOV 5 call options) yesterday for a couple of reasons.

1 - double bottom chart (2.875)formation with roughly 900k shares trading hands)
2 - Saloman Bros. has a major equity stake in the co (they took it public)
3 - Cash position is roughly $2.30 per share (meaning the company was being valued at only $.60)
4 - Interesting cervical cancer detection product begging to be marketed.
5 - Ouster of CEO (probably by Saloman)because he was not marketing the product quickly enough)

As for today:

Heavy volume 2.2 million shares, stock up 30%+. Good press release however I don't think it was strong enough to generate today's reaction. I think (maybe hope) this stock will rebound to the $7 or $8 mark with some additional news in the next few weeks.

What are your thoughts.

Dave
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext